"Technology has been disrupting jobs, changing the way people work, destroying jobs ... for decades," David Solomon says.

GSK agreed to acquire Rapt Therapeutics for $2.2 billion on Tuesday, a move that sent Rapt’s shares sharply higher and signaled fresh momentum in drug industry dealmaking. The agreement brings a